Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

Pierre Fabre reports antioxidants

July 26, 1996

Hoechst Marion Roussel synthesizes TNF-alpha production inhibitor

July 19, 1996

RB-106: INSERM's NEP/ACE inhibitor

July 19, 1996

Serine elastase inhibitor: A promising cardiovascular therapeutic

July 19, 1996

Alexion awarded U.S. patent for monoclonal antibodies

July 19, 1996

Lynx Therapeutics' LR-3280 licensed to Tanabe Seiyaku

July 19, 1996

FO-2047: Kitasato Institute's lipid peroxidation inhibitor

July 19, 1996

LDL oxidation inhibitors as arteriosclerosis/myocardial ischemia treatment from Chugai

July 19, 1996

Benzofuran smooth muscle proliferation inhibitors from Lilly

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...